A citation-based method for searching scientific literature

Lu Yang, Anthony K N Chan, Kazuya Miyashita, Christopher D Delaney, Xi Wang, Hongzhi Li, Sheela Pangeni Pokharel, Sandra Li, Mingli Li, Xiaobao Xu, Wei Lu, Qiao Liu, Nicole Mattson, Kevin Yining Chen, Jinhui Wang, Yate-Ching Yuan, David Horne, Steven T Rosen, Yadira Soto-Feliciano, Zhaohui Feng, Takayuki Hoshii, Gang Xiao, Markus Müschen, Jianjun Chen, Scott A Armstrong, Chun-Wei Chen. Nat Commun 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
John G Doench, Nicolo Fusi, Meagan Sullender, Mudra Hegde, Emma W Vaimberg, Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard,[...]. Nat Biotechnol 2016
50

Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements.
Josh Tycko, Michael Wainberg, Georgi K Marinov, Oana Ursu, Gaelen T Hess, Braeden K Ego, Aradhana, Amy Li, Alisa Truong, Alexandro E Trevino,[...]. Nat Commun 2019
41
50


The common γ-chain cytokine receptor: tricks-and-treats for T cells.
Adam T Waickman, Joo-Young Park, Jung-Hyun Park. Cell Mol Life Sci 2016
45
50

Genetic screens in human cells using the CRISPR-Cas9 system.
Tim Wang, Jenny J Wei, David M Sabatini, Eric S Lander. Science 2014
50

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.
Luke A Gilbert, Matthew H Larson, Leonardo Morsut, Zairan Liu, Gloria A Brar, Sandra E Torres, Noam Stern-Ginossar, Onn Brandman, Evan H Whitehead, Jennifer A Doudna,[...]. Cell 2013
50

Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia.
Melissa M Berrien-Elliott, Amanda F Cashen, Celia C Cubitt, Carly C Neal, Pamela Wong, Julia A Wagner, Mark Foster, Timothy Schappe, Sweta Desai, Ethan McClain,[...]. Cancer Discov 2020
34
50

NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.
Garnet Suck, Marcus Odendahl, Paulina Nowakowska, Christian Seidl, Winfried S Wels, Hans G Klingemann, Torsten Tonn. Cancer Immunol Immunother 2016
171
50

Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology.
Paula Schmidt, Martin J Raftery, Gabriele Pecher. Front Immunol 2021
26
50

Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
M J Robertson, K J Cochran, C Cameron, J M Le, R Tantravahi, J Ritz. Exp Hematol 1996
305
50

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
Xiaowen Tang, Lin Yang, Zheng Li, Ansel P Nalin, Haiping Dai, Ting Xu, Jia Yin, Fengtao You, Mingqing Zhu, Wenhong Shen,[...]. Am J Cancer Res 2018
182
50

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Caroline Duault, Anil Kumar, Adeleh Taghi Khani, Sung June Lee, Lu Yang, Min Huang, Christian Hurtz, Bryan Manning, Lucy Ghoda, Tinisha McDonald,[...]. Blood 2021
8
50

IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages.
Meili Zhang, Bernard Wen, Olga M Anton, Zhengsheng Yao, Sigrid Dubois, Wei Ju, Noriko Sato, David J DiLillo, Richard N Bamford, Jeffrey V Ravetch,[...]. Proc Natl Acad Sci U S A 2018
57
50

Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics.
Nigel G Kooreman, Patricia E de Almeida, Jonathan P Stack, Raman V Nelakanti, Sebastian Diecke, Ning-Yi Shao, Rutger-Jan Swijnenburg, Veronica Sanchez-Freire, Elena Matsa, Chun Liu,[...]. Cell Rep 2017
18
50

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
Aaron J Wilk, Madeline J Lee, Bei Wei, Benjamin Parks, Ruoxi Pi, Giovanny J Martínez-Colón, Thanmayi Ranganath, Nancy Q Zhao, Shalina Taylor, Winston Becker,[...]. J Exp Med 2021
42
50

Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.
Hyun Gul Yang, Moon Cheol Kang, Tae Yoon Kim, Injung Hwang, Hyun Tak Jin, Young Chul Sung, Ki-Seong Eom, Sae Won Kim. J Immunother Cancer 2019
12
50

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Emily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, Walker S Lahr, Branden A Smeester, Margaret R Crosby, Cara-Lin Lonetree, Kenta Yamamoto, Laura Bendzick, Jeffrey S Miller,[...]. Mol Ther 2020
62
50

Human NK Cell Diversity in Viral Infection: Ramifications of Ramification.
Dara M Strauss-Albee, Catherine A Blish. Front Immunol 2016
17
50

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.
Maria Therese Ahlen, Anne Husebekk, Mette Kjaer Killie, Bjørn Skogen, Tor B Stuge. Blood 2009
42
50

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
50

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.
Megan A Cooper, Jennifer E Bush, Todd A Fehniger, Jeffrey B VanDeusen, Ross E Waite, Yang Liu, Hector L Aguila, Michael A Caligiuri. Blood 2002
327
50

CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
Andrew D Hildreth, Luke Riggan, Timothy E O'Sullivan. STAR Protoc 2020
3
50

Highly efficient Cas9-mediated transcriptional programming.
Alejandro Chavez, Jonathan Scheiman, Suhani Vora, Benjamin W Pruitt, Marcelle Tuttle, Eswar P R Iyer, Shuailiang Lin, Samira Kiani, Christopher D Guzman, Daniel J Wiegand,[...]. Nat Methods 2015
771
50

Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
Sheena M Saayman, Daniel C Lazar, Tristan A Scott, Jonathan R Hart, Mayumi Takahashi, John C Burnett, Vicente Planelles, Kevin V Morris, Marc S Weinberg. Mol Ther 2016
87
50


Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells.
Hans Klingemann, Laurent Boissel, Frances Toneguzzo. Front Immunol 2016
215
50

Multiplicity of infection/multiplicity of confusion.
P Shabram, E Aguilar-Cordova. Mol Ther 2000
25
50

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.
Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan S Weissman, Adam P Arkin, Wendell A Lim. Cell 2013
50

NK cell-based cancer immunotherapy: from basic biology to clinical application.
Yang Li, Jie Yin, Ting Li, Shan Huang, Han Yan, JianMei Leavenworth, Xi Wang. Sci China Life Sci 2015
33
50

High levels of AAV vector integration into CRISPR-induced DNA breaks.
Killian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, Mikołaj P Zaborowski, Adrienn Volak, Stefan E Spirig, Alissa Muller, Alexander A Sousa, Shengdar Q Tsai, Niclas E Bengtsson,[...]. Nat Commun 2019
121
50


Natural killer cells, viruses and cancer.
A Cerwenka, L L Lanier. Nat Rev Immunol 2001
638
50

Drug target validation in primary human natural killer cells using CRISPR RNP.
Jai Rautela, Elliot Surgenor, Nicholas D Huntington. J Leukoc Biol 2020
8
50

A potential role for interleukin-15 in the regulation of human natural killer cell survival.
W E Carson, T A Fehniger, S Haldar, K Eckhert, M J Lindemann, C F Lai, C M Croce, H Baumann, M A Caligiuri. J Clin Invest 1997
327
50

Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed.
G Minowada, L A Jarvis, C L Chi, A Neubüser, X Sun, N Hacohen, M A Krasnow, G R Martin. Development 1999
429
50

Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma.
Björn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, Amanda L Robichaud, Amy Saur Conway, Ann M Morgan, Gabriela Alexe, Nathan J Schauer, Xiaoxi Liu, Gregory H Bird,[...]. J Exp Med 2018
42
50

EWS-FLI1 employs an E2F switch to drive target gene expression.
Raphaela Schwentner, Theodore Papamarkou, Maximilian O Kauer, Vassilios Stathopoulos, Fan Yang, Sven Bilke, Paul S Meltzer, Mark Girolami, Heinrich Kovar. Nucleic Acids Res 2015
28
50

STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Thomas G P Grunewald, Isabel Diebold, Irene Esposito, Stephanie Plehm, Kristina Hauer, Uwe Thiel, Patricia da Silva-Buttkus, Frauke Neff, Rebekka Unland, Carsten Müller-Tidow,[...]. Mol Cancer Res 2012
72
50

Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma.
Kirsten M Johnson, Cenny Taslim, Ranajeet S Saund, Stephen L Lessnick. PLoS One 2017
22
50

Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.
Kathleen I Pishas, Christina D Drenberg, Cenny Taslim, Emily R Theisen, Kirsten M Johnson, Ranajeet S Saund, Ioana L Pop, Brian D Crompton, Elizabeth R Lawlor, Franck Tirode,[...]. Mol Cancer Ther 2018
28
50

Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.
Lehang Lin, Moli Huang, Xianping Shi, Anand Mayakonda, Kaishun Hu, Yan-Yi Jiang, Xiao Guo, Li Chen, Brendan Pang, Ngan Doan,[...]. Nucleic Acids Res 2019
28
50


Modeling initiation of Ewing sarcoma in human neural crest cells.
Cornelia von Levetzow, Xiaohua Jiang, Ynnez Gwye, Gregor von Levetzow, Long Hung, Aaron Cooper, Jessie Hao-Ru Hsu, Elizabeth R Lawlor. PLoS One 2011
116
50

Regulation of gene transcription by Polycomb proteins.
Sergi Aranda, Gloria Mas, Luciano Di Croce. Sci Adv 2015
186
50

The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
Marta Mendiola, Jaime Carrillo, Eva García, Enzo Lalli, Teresa Hernández, Enrique de Alava, Franck Tirode, Olivier Delattre, Purificación García-Miguel, Fernando López-Barea,[...]. Int J Cancer 2006
58
50

Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma.
Kunal Gangwal, Devin Close, Camille A Enriquez, Christopher P Hill, Stephen L Lessnick. Genes Cancer 2010
41
50

GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.
Elspeth Beauchamp, Gulay Bulut, Ogan Abaan, Kevin Chen, Akil Merchant, William Matsui, Yoshimi Endo, Jeffrey S Rubin, Jeffrey Toretsky, Aykut Uren. J Biol Chem 2009
121
50

Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma.
Bárbara Kunzler Souza, Patrícia Luciana da Costa Lopez, Pâmela Rossi Menegotto, Igor Araujo Vieira, Nathalia Kersting, Ana Lúcia Abujamra, André T Brunetto, Algemir L Brunetto, Lauro Gregianin, Caroline Brunetto de Farias,[...]. Mol Neurobiol 2018
16
50

Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor.
Y Qi, J Cai, Y Wu, R Wu, J Lee, H Fu, M Rao, L Sussel, J Rubenstein, M Qiu. Development 2001
265
50

GLI transcription factors: mediators of oncogenic Hedgehog signalling.
Maria Kasper, Gerhard Regl, Anna-Maria Frischauf, Fritz Aberger. Eur J Cancer 2006
302
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.